Worth reading
37Immaterial
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
0
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of the Ninth Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
Intended allottee
EVO FUND (allottee of the previously issued rights)
Terms of the stock acquisition rights
Number of Stock Acquisition Rights
Total issued: 570,000 rights; unexercised balance as of the end of June 2026: 515,000 rights
Procedures under the Corporate Code of Conduct
Reported compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Timing 9 March 2026 / Type Issuance of the Ninth Series of Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the Ninth Series of Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause) |
| Intended allottee | EVO FUND (allottee of the previously issued rights) |
| Number of Stock Acquisition Rights | Total issued: 570,000 rights; unexercised balance as of the end of June 2026: 515,000 rights |
| Procedures under the Corporate Code of Conduct | Reported compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 9 March 2026 / Type Issuance of the Ninth Series of Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (23)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company has not provided an explanation for why there were no exercises.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.